![Bradford Conlan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Bradford Conlan first degree
Entity | Entity type | Industry | |
---|---|---|---|
Okogen, Inc.
![]() Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bradford Conlan via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
University of California, Los Angeles | College/University | Doctorate Degree | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree | |
David Geffen School of Medicine | College/University | Doctorate Degree | |
Anderson School of Management | College/University | Masters Business Admin | |
OccuRx Pty Ltd
![]() OccuRx Pty Ltd BiotechnologyHealth Technology OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia. | Biotechnology | Chief Executive Officer | |
Yellowbrick Bio LLC
![]() Yellowbrick Bio LLC Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Yellowbrick Bio LLC is a company that manufactures ophthalmological pharmaceutical products. The company is based in Solana Beach, CA. The company was founded in 2020 by Brian Matthew Strem. Yellowbrick Bio was acquired by Kiora Pharmaceuticals, Inc. on October 21, 2021 for $7.22 million. | Pharmaceuticals: Major | Founder | |
Bayon Therapeutics, Inc. | Founder Founder |
Statistics
International
United States | 9 |
Australia | 2 |
Sectoral
Consumer Services | 6 |
Health Technology | 4 |
Operational
Director/Board Member | 7 |
Founder | 5 |
Chief Executive Officer | 3 |
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 2 |
Most connected contacts
Insiders | |
---|---|
Eric Daniels | 7 |
Brian Strem | 6 |
Joshua Moriarty | 1 |
- Stock Market
- Insiders
- Bradford Conlan
- Company connections